Health Law & Business News

Drug Middlemen Face First Ever Regulations in Minnesota (Corrected)

March 20, 2019, 9:41 PMUpdated: March 21, 2019, 1:32 PM

Middlemen negotiating drug prices for health insurers would be regulated in Minnesota for the first time under a bill headed to a second Senate committee in early April.

The Minnesota Commerce and Consumer Protection Finance and Policy Committee March 20 approved by voice vote SF 278, which would establish licensing fees and other standards for pharmacy benefit managers, who negotiate drug prices between manufacturers and insurers. It now heads to the Senate Finance Committee where it could get scrutiny as early as the week beginning April 1, a Senate spokeswoman said.

If signed into law, Minnesota would become the...

To read the full article log in. To learn more about a subscription click here.